Home » Newsletters » BioWorld Science

BioWorld Science

April 28, 2016

View Archived Issues

Researchers present promising data for the novel Mdm2 inhibitor NVP-HDM201

Arbaclofen ER compared to baclofen in multiple sclerosis patients with spasticity

GlaxoSmithKline and Anacor Pharmaceuticals exploit novel mechanism for treating tuberculosis

SAR-428926, a novel ADC with promising activity in preclinical models of cancer

Pneumococcal infection model reveals protective effects of B-cell epitopes

Bayer Schering Pharma patents CDK inhibitors

Merck & Co. discloses ROMK blockers

Positive results reported from two phase III studies of SUN-101/eFlow for COPD

X-Chem achieves milestone in Alexion collaboration

Janssen Pharmaceutica describes FFAR1 agonists

Adimab enters two new antibody collaborations

Protagonist Therapeutics presents LPAM-1 receptor antagonists

Positive results from phase II study of AZP-531 in Prader-Willi Syndrome

First patient randomized in the dalGenE phase III cardiovascular outcomes trial

Cosmo Technologies reports AR and GR antagonists

Cumberland Pharmaceuticals commences new systemic sclerosis program for ifetroban

Sanofi enters collaborations to predict diabetes medication adherence

Grant supports University of Manchester's research in frontotemporal lobar degeneration

FDA extends PDUFA date for Heplisav-B BLA

Biosortia announces new oncology research projects

Sanofi makes proposal to acquire Medivation

Clinical trial investigates gene therapy for Batten disease CLN6

First patient dosed in phase I trial of Agenus' AGEN-1884

Shionogi reports promising phase II data for Japanese Cedar pollen sublingual immunotherapy tablet

E.U. approval for TachoSil for use in neurological surgery

Lonsurf approved in Europe

FDA accepts OPKO's resubmitted NDA for calcifediol

AbGenomics reports final results from phase II trial of neihulizumab in psoriatic arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...